150 related articles for article (PubMed ID: 35549728)
1. Defective expression of C20orf54 in esophageal dysplasia: a possible biomarker of esophageal carcinoma for early detection.
Li M; Kong J; Wang L; Yan H; Liang W; Wang N; Zhao J
World J Surg Oncol; 2022 May; 20(1):155. PubMed ID: 35549728
[TBL] [Abstract][Full Text] [Related]
2. ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
Li M; Cui X; Shen Y; Dong H; Liang W; Chen Y; Hu J; Li S; Kong J; Li H; Zhao J; Li F
Hum Pathol; 2015 May; 46(5):707-15. PubMed ID: 25732110
[TBL] [Abstract][Full Text] [Related]
3. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
4. Association of the plasma riboflavin levels and riboflavin transporter (C20orf54) gene statuses in Kazak esophageal squamous cell carcinoma patients.
Ainiwaer J; Tuerhong A; Hasim A; Chengsong D; Liwei Z; Sheyhidin I
Mol Biol Rep; 2013 May; 40(5):3769-75. PubMed ID: 23275236
[TBL] [Abstract][Full Text] [Related]
5. USP9X expression correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Peng J; Hu Q; Liu W; He X; Cui L; Chen X; Yang M; Liu H; Wei W; Liu S; Wang H
Diagn Pathol; 2013 Oct; 8():177. PubMed ID: 24152793
[TBL] [Abstract][Full Text] [Related]
6. [Expression of FBXW7 in esophageal squamous cell carcinoma and its clinical significance].
Yu H; Ling T; Shi R; Shu Q; Li Y; Tan Z
Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):347-51. PubMed ID: 26463024
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Liu Z; Yang T; Xu Z; Cao X
Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
[TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the telomerase RNA component gene as a new genetic marker for disease progression and prognosis in esophageal squamous cell carcinoma.
Wang JD; Ma J; Wang FY; Peng LB; Wang X; Shi SS; Ma HH; Lu ZF; Lu GM; Zhou XJ
Dis Esophagus; 2013; 26(7):737-45. PubMed ID: 23317107
[TBL] [Abstract][Full Text] [Related]
10. Associations of carboxypeptidase 4 with ALDH1A1 expression and their prognostic value in esophageal squamous cell carcinoma.
Sun L; Cao J; Guo C; Burnett J; Yang Z; Ran Y; Sun D
Dis Esophagus; 2017 Jun; 30(6):1-5. PubMed ID: 28475748
[TBL] [Abstract][Full Text] [Related]
11. Independent prognostic role of PD-L1expression in patients with esophageal squamous cell carcinoma.
Jiang D; Song Q; Wang H; Huang J; Wang H; Hou J; Li X; Xu Y; Sujie A; Zeng H; Tan L; Hou Y
Oncotarget; 2017 Jan; 8(5):8315-8329. PubMed ID: 28039448
[TBL] [Abstract][Full Text] [Related]
12. TGFBR3 is an independent unfavourable prognostic marker in oesophageal squamous cell cancer and is positively correlated with Ki-67.
Zhang X; Chen Y; Li Z; Han X; Liang Y
Int J Exp Pathol; 2020 Dec; 101(6):223-229. PubMed ID: 33146446
[TBL] [Abstract][Full Text] [Related]
13. PIK3CA promotes proliferation and motility but is unassociated with lymph node metastasis or prognosis in esophageal squamous cell carcinoma.
Zheng S; Yang C; Lu M; Liu Q; Liu T; Dai F; Gao X; Sheyhidin I; Lu X
Hum Pathol; 2016 Jul; 53():121-9. PubMed ID: 27001433
[TBL] [Abstract][Full Text] [Related]
14. γ-Glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors.
Takemura K; Kawachi H; Eishi Y; Kitagaki K; Negi M; Kobayashi M; Uchida K; Inoue J; Inazawa J; Kawano T; Board PG
Hum Pathol; 2014 Feb; 45(2):331-41. PubMed ID: 24342434
[TBL] [Abstract][Full Text] [Related]
15. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness.
Chen YZ; Cui XB; Hu JM; Zhang WJ; Li SG; Yang L; Shen XH; Liu CX; Pan QF; Yu SY; Yuan XL; Yang L; Gu WY; Chen JZ; Wang LD; Li F
APMIS; 2013 Oct; 121(10):908-18. PubMed ID: 23659763
[TBL] [Abstract][Full Text] [Related]
17. The correlation between XIAP gene polymorphisms and esophageal squamous cell carcinoma susceptibility and prognosis in a Chinese population.
Peng H; Wang LG; Wang XZ; Liu AJ
Pathol Res Pract; 2017 Dec; 213(12):1482-1488. PubMed ID: 29037837
[TBL] [Abstract][Full Text] [Related]
18. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
19. Expression and Significance of TRIM 28 in Squamous Carcinoma of Esophagus.
Liu B; Li X; Liu F; Li F; Wei S; Liu J; Lv Y
Pathol Oncol Res; 2019 Oct; 25(4):1645-1652. PubMed ID: 30484263
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
Lin X; Xu XY; Chen QS; Huang C
Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]